FDA Inspection 1075279 — Annora Pharma Private Limited
The FDA completed an inspection of Annora Pharma Private Limited on Nov 10, 2018 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 10, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hyderabad (India)